Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2012 it was $12.04M, down 5.5% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $12.04M | -5.5% |
| FY2011 | Dec 31, 2011 | $12.73M | -9.9% |
| FY2010 | Dec 31, 2010 | $14.14M | – |
See a number that looks wrong?